Literature DB >> 1103722

[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

H Lode, B Kemmerich, P Koeppe.   

Abstract

Using a randomized crossover design involving 12 normal subjects, we studied comparatively the pharmacokinetics and tolerance of three aminoglycoside antibiotics, gentamicin, sisomicin, and tobramycin. Serum concentrations were determined during 8 h and the urine recovery rate was determined within 24 h after a 1-h intravenous infusion of the respective antibiotic in a dose of 1 mg/kg of body weight. Microbiological assay was performed with the agar diffusion test (Bacillus subtilis); pharmacokinetic calculations were performed by means of a digital computer on the basis of a mathematical model of an open, two-compartment system. Of the three antibiotics studied, gentamicin showed the lowest concentration in serum after termination of the 1-h infusion (3.85 +/- 0.67 mug/ml), and the serum-regression curve steadily lay below those of the two other antibiotics. Sisomicin had the highest serum concentrations (4,66 +/- 1.24 mug/ml) and the serum-level curve exceeded that of the two other antibiotics. Tobramycin occupied a position between sisomicin and gentamicin in form of its serum level characteristics. Corresponding to the serum kinetics we also found slight differences in the pharmacokinetic parameters, especially in serum half-lives, elimination constants, and areas under the serum level curves. The test of liver and kidney functions and the hematological systems, as well as the function of the stato-acusticus nerve, showed no pathological changes by any of the three antibiotics tested.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103722      PMCID: PMC429354          DOI: 10.1128/AAC.8.4.396

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.

Authors:  R L JAO; G G JACKSON
Journal:  JAMA       Date:  1964-09-14       Impact factor: 56.272

2.  Serum levels of gentamicin and tobramycin after slow intravenous bolus injection.

Authors:  B C Stratford; S Dixson; A J Cobcroft
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

3.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

4.  The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.

Authors:  D Kaye; M E Levison; E D Labovitz
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

5.  Pharmacology of gentamicin in man.

Authors:  L J Riff; G G Jackson
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Pharmacokinetic studies of tobramycin and gentamicin.

Authors:  V K Simon; E U Mösinger; V Malerczy
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

7.  Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans.

Authors:  K G Naber; S R Westenfelder; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

8.  Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.

Authors:  W R Lockwood; J D Bower
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

9.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

10.  In vitro bactericidal effectiveness of four aminoglycoside antibiotics.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

View more
  17 in total

1.  The renal handling of polybasic drugs. 1. Gentamicin and aprotinin in intact animals.

Authors:  M Just; G Erdmann; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  Sensitivity of strains of enteropathogenic Escherichia coli to tobramycin and other antibiotics.

Authors:  N Konforti; B Lev; N Hanner
Journal:  Med Microbiol Immunol       Date:  1977-12-27       Impact factor: 3.402

3.  Assay of serum tobramycin levels with the Bactec 460.

Authors:  L E Phillips; R R Martin; L O Gentry; T E Rogers
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

4.  Comparison of netilmicin and gentamicin pharmacokinetics in humans.

Authors:  M Chung; R Costello; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

5.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

Review 6.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 7.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Pharmacokinetic study of sisomicin in humans.

Authors:  M Chung; J J Schrogie; S Symchowicz
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

9.  Comparison of activity of sisomicin and gentamicin in mouse protection tests with gram-negative bacilli.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

10.  Pharmacokinetic parameters of sisomicin.

Authors:  B R Meyers; S Z Hirschman; S Yancovitz; B Ribner
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.